Cosciens Biopharma Inc
(CSCI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 08-1996 | 08-1993 | 08-1992 | 08-1991 | 08-1990 | |
| Gross Profit | 6,361 | 901 | 5,800 | 4,555 | 3,628 |
| Operating Expenses | 792 | 701 | 319 | 0 | 0 |
| Operating Income | -792 | -701 | -319 | N/A | N/A |
| Pre-tax Income | -792 | -701 | -319 | 0 | 0 |
| Net Income Continuous | -792 | -701 | -319 | N/A | N/A |
| Net Income | $-792 | $-701 | $-319 | $N/A | $N/A |
| EBITDA(a) | $501 | $-156 | $163 | $501 | $405 |